Search
Meditek’s Main Subsidiary Secures 200 Million Yuan Capital Boost from Shaoxin Integrated Circuits
10 hour ago /
Read about 0 minute
Author：小编
On March 24, Meditek made an announcement stating that its primary subsidiary, Zhejiang Meditek Optical Semiconductor Co., Ltd., had finalized the industrial and commercial registration process for its capital increase and share expansion. This strategic move successfully brought in Fuzhe Shaoxin Integrated Circuit Industry Fund as a new investor, resulting in a substantial cash infusion of 200 million yuan. Following the capital increase, the optical semiconductor company’s registered capital has been elevated to 1,101,447,503 yuan. Meditek retains a majority stake of 82.44%, while Fuzhe Shaoxin now holds an 8.40% share.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
